NASDAQ · EQUITY · ENHANCED MARKET DYNAMICS
LGND
Ligand Pharmaceuticals IncorporatedUS · Healthcare · Biotechnology
CURRENT COMPLETED-WEEK READ
Strongly constructive
The latest completed-week readings are broadly supportive. Conditions are positive and have strengthened over the latest four completed weeks.
- Completed week
- 28 Aug 2026
- Latest close
- USD 280.49
- Evidence
- 156 weeks
COMPLETED-WEEK OVERVIEW
Price and market conditions over time
5 supportive · 0 cautious
THE FULL PRICE CYCLE
Follow the journey from one zone to the other
Each state uses completed-week information available at that point.
Lower zone
Price establishes residence near the bottom of its long-cycle range. Improving EMD separates early repair from continued deterioration.
Upward journey
Price leaves the lower zone while EMD confirms improving participation. The objective is the broader move toward the upper zone, not a short weekly trade.
Upper zone
Price establishes residence near the top of its long-cycle range. This is the profit-harvest area, with EMD watched for exhaustion and loss of support.
Downward journey
Price leaves the upper zone while EMD weakens. The reverse cycle remains active until lower-zone residence is confirmed again.
CURRENT READINGS
What the latest week shows
Completed-week values
01
Underlying pressure
Strengthening beneath price
4-week change -1.03
02
Trend and deviation
Price structure supports the trend
Trend gate active
03
Momentum and SMI
Momentum is supportive
SMI 0.94
04
Price-volume pressure
Volume is leaning against the close
Volume ratio 0.60x
05
Relative leadership
Leadership is supportive
4-week change -11.45
06
Modeled Trend
Modeled Trend is supportive
Smoothed Modeled Trend 0.86